Cytosorbents (CTSO) Other Accumulated Expenses (2023 - 2025)

Cytosorbents (CTSO) has 3 years of Other Accumulated Expenses data on file, last reported at $965000.0 in Q2 2025.

• For the quarter ending Q2 2025, Other Accumulated Expenses changed N/A year-over-year to $965000.0; the trailing twelve-month figure through Jun 2025 stood at $965000.0 (changed N/A YoY), and the FY2024 full-year result was $812000.0, down 18.11% from the prior year.
• Other Accumulated Expenses for Q2 2025 stood at $965000.0, up from $796925.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $991545.0 in Q4 2023 and bottomed at $796925.0 in Q1 2025.
• The 3-year median for Other Accumulated Expenses is $888500.0 (2024), against an average of $891367.5.
• Peak annual rise in Other Accumulated Expenses reached 18.11% in 2024, while the deepest fall reached 18.11% in 2024.
• A 3-year view of Other Accumulated Expenses shows it stood at $991545.0 in 2023, then fell by 18.11% to $812000.0 in 2024, then climbed by 18.84% to $965000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $965000.0 (Q2 2025), $796925.0 (Q1 2025), and $812000.0 (Q4 2024), per Business Quant data.

Peer Comparison